x
Filter:
Filters applied
- Editorials
- EditorialRemove Editorial filter
- Wright, R ScottRemove Wright, R Scott filter
- Mayo Clinic ProceedingsRemove Mayo Clinic Proceedings filter
Publication Date
Please choose a date range between 2015 and 2023.
Editorials
6 Results
- Editorial
Decreasing Door-to-Diagnosis Time in Cardiac Amyloidosis: A Simple “One-Stop Shop” Approach
Mayo Clinic ProceedingsVol. 98Issue 1p7–10Published in issue: January, 2023- Martha Grogan
- R. Scott Wright
Cited in Scopus: 0Cardiac amyloidosis (CA) remains a challenging disease to detect and to diagnose. Recent advancements in treatment necessitate more rapid diagnosis so that treatment can be initiated as early as possible. In this issue of Mayo Clinic Proceedings, Bézard et al1 report on the real-life evaluation of an algorithm for the diagnosis of CA. The authors propose a “one-stop shop” approach to the diagnosis of CA by performing 4 tests simultaneously at the first day of a visit: serum and urine screening for monoclonal protein (MCP), nuclear cardiac scintigraphy, salivary gland biopsy, and DNA TTR testing. - Editorial
Homeless With a Heart Attack in America—A Double Whammy
Mayo Clinic ProceedingsVol. 95Issue 4p626–628Published online: March 19, 2020- R. Scott Wright
- Joseph G. Murphy
Cited in Scopus: 0We think sometimes that poverty is only being hungry, naked, and homeless. The poverty of being unwanted, unloved, and uncared for is the greatest poverty. Mother Teresa - Editorial
Mitigating Risk Patients With Dyslipidemia: A Statin a Day Does Not Always Keep the Doctor Away in Those With Elevated Triglycerides
Mayo Clinic ProceedingsVol. 94Issue 9p1659–1661Published in issue: September, 2019- R. Scott Wright
- Joseph G. Murphy
Cited in Scopus: 0Coronary atherosclerosis risk is strongly associated with elevated levels of low-density lipoprotein cholesterol (LDL-C).1 Elevated serum triglycerides are also associated with increased coronary risk, but controversy exists over whether triglycerides (TGs) themselves are atherogenic or merely reflect a surrogate marker for other cardiometabolic disorders including low high-density lipoprotein cholesterol (HDL-C), diabetes mellitus, and obesity.2-5 An important clinical question is whether patients at high atherogenic risk, currently on statin medication, need additional specific treatment for hypertriglyceridemia if it is present. - Editorial
A New Fix for the Bishop’s Hat, Let’s Give It Time to Wear Before We Pass Judgment
Mayo Clinic ProceedingsVol. 94Issue 1p4–6Published in issue: January, 2019- Joseph G. Murphy
- Sushil Allen Luis
- R. Scott Wright
Cited in Scopus: 0Zhou Enlai (the first premier of the People’s Republic of China), when asked his opinion of the impact of the French Revolution (of 1789) in an interview conducted in 1968 during the height of the Paris student riots, is reported to have stated that it was “too early to tell.” - Editorial
Social Media Posts and Search Engine Queries as the Canary in the Coal Mine for Public Health Surveillance
Mayo Clinic ProceedingsVol. 93Issue 9p1155–1157Published in issue: September, 2018- Joseph G. Murphy
- R. Scott Wright
Cited in Scopus: 0A bird doesn’t sing because it has an answer, it sings because it has a songMaya Angelou - Editorial
Ischemic Left Ventricular Aneurysm and Anticoagulation: Is It the Clot or the Plot That Needs Thinning?
Mayo Clinic ProceedingsVol. 90Issue 4p428–431Published online: March 6, 2015- Joseph G. Murphy
- R. Scott Wright
- Gregory W. Barsness
Cited in Scopus: 4All truths are easy to understand once they are discovered; the point is to discover them.—Galileo Galilei (1564-1642)